Kiromic BioPharma Inc. (KRBP)
1.50
0.00 (0.00%)
At close: Feb 28, 2025, 3:17 PM
0.00
-100.00%
After-hours: Dec 31, 1969, 07:00 PM EST
Kiromic BioPharma Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Cash & Equivalents | 1.14M | 3.2M | 645.2K | 25.35M | 10.15M | 1.93M | 384.3K |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 21K | 21.4K | 24.4K | 31.1K | 24.4K | 24.4K | 17.8K |
| Receivables | n/a | n/a | n/a | 16.2K | n/a | n/a | 24.3K |
| Inventory | n/a | n/a | n/a | n/a | n/a | 22.2K | 16.3K |
| Other Current Assets | 2.16M | 1.23M | 1.04M | 3.4M | 1.18M | 89.1K | 135.3K |
| Total Current Assets | 3.3M | 4.43M | 1.69M | 27.07M | 10.74M | 2.04M | 560.2K |
| Property-Plant & Equipment | 5.22M | 7.72M | 10.25M | 3.63M | 2.07M | 587.9K | 298K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 5.24M | 7.74M | 10.28M | 3.66M | 2.09M | 612.3K | 315.8K |
| Total Assets | 8.54M | 12.17M | 11.97M | 30.73M | 12.83M | 2.65M | 876K |
| Account Payables | 2.68M | 2.14M | 7.31M | 2.21M | 665.2K | 452.4K | 219.1K |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Short-Term Debt | 1.37M | 14.63M | 4.95M | 454.5K | 468K | n/a | n/a |
| Other Current Liabilities | 16.86M | 3.61M | 1.02M | 741K | 334.4K | 221.3K | 391.6K |
| Total Current Liabilities | 20.9M | 20.38M | 13.28M | 3.41M | 1.47M | 673.7K | 610.7K |
| Long-Term Debt | 13.7M | 911.5K | 4.46M | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | -228K | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Liabilities | 13.47M | 911.5K | 4.46M | n/a | n/a | n/a | n/a |
| Total Liabilities | 21.13M | 21.29M | 17.74M | 3.41M | 1.47M | 673.7K | 610.7K |
| Total Debt | 14.57M | 15.54M | 9.41M | 454.5K | 468K | n/a | n/a |
| Common Stock | 2K | 1.26K | 648.00 | 9.3K | 1.2K | n/a | n/a |
| Retained Earnings | -149.79M | -122.9M | -101.95M | -67.22M | -41.63M | -22.43M | -18.7M |
| Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | -274.2K |
| Shareholders Equity | -12.59M | -9.12M | -5.77M | 27.32M | 11.36M | 1.98M | 265.3K |
| Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a |